Unique ID issued by UMIN | UMIN000040642 |
---|---|
Receipt number | R000046387 |
Scientific Title | Assessment of neointimal coverage using two different imaging modalities at 2-week and 6-month after ultrathin vs thin strut drug-eluting stent implantation in coronary artery disease patients with ST elevation myocardial infarction -high-resolution angioscopy and OCT study- |
Date of disclosure of the study information | 2020/07/01 |
Last modified on | 2022/12/05 09:16:38 |
Assessment of neointimal coverage using two different imaging modalities at 2-week and 6-month after ultrathin vs thin strut drug-eluting stent implantation in coronary artery disease patients with ST elevation myocardial infarction -high-resolution angioscopy and OCT study-
NAGAKUTE-CASTLE study
Assessment of neointimal coverage using two different imaging modalities at 2-week and 6-month after ultrathin vs thin strut drug-eluting stent implantation in coronary artery disease patients with ST elevation myocardial infarction -high-resolution angioscopy and OCT study-
NAGAKUTE-CASTLE study
Japan |
Acute myocardial infarction
Cardiology |
Others
NO
To compare the neointimal coverage at 14 days after stent placement (Orsiro and Xience) using the imaging devices of OCT/OFDI and angioscopy.
Efficacy
Neointimal coverage rate at 2-week after stent implantation
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Orsiro stent
Xience stent
20 | years-old | <= |
Not applicable |
Male and Female
(1) Patients with st-elevation myocardial infarction less than 12 hours after onset (Orsiro group: 55 cases, XIENCE group: 55 cases)
(2) Patients who can be followed up in all clinical situations
(3) Patients who can be observed by angiography, OCT/OFDI and angioscopy 2 weeks after PCI
(4) Patients who can be observed by angiography, OCT/OFDI 6 months after surgery
(5) Patients with medical indication of PCI
(1) Patients who cannot obtain written consent after oral consent by the patient or his/her legal representative
(2) Patients with cardiogenic shock
(3) Hemodialysis patients
(4) Left main lesion / Bifurcation lesion requiring two stents / In-stent restenosis lesion
(5) The target lesion is in the arterial bypass graft or saphenous vein bypass graft, or distal to the graft anastomosis site
(6) Patients who are contraindicated for antiplatelet therapy or anticoagulant therapy
(7) Patients who have difficulty in proper drug therapy
(8) Patients who have a contraindication to contrast agents or have allergies to contrast agents
(9) Patients scheduled for cardiac surgery within 6 months
(10) Patients who have participated in another study and have not completed the observation period in that study
(11) Patients who are judged to be unfavorable for participation in this study by the investigator and investigator
110
1st name | Tetsuya |
Middle name | |
Last name | Amano |
Aichi Medical University
Cardiology
480-1195
1-1 Yazakokarimata Nagakute, Aichi
0561-62-3311
amanotaha@yahoo.co.jp
1st name | Hirohiko |
Middle name | |
Last name | Ando |
Aichi Medical University
Cardiology
480-1195
1-1 Yazakokarimata Nagakute, Aichi
0561-62-3311
anhiro@aichi-med-u.ac.jp
Aichi Medical University
None
Self funding
Ethics Committee of Aichi Medical University
1-1 Yazakokarimata Nagakute, Aichi
0561-62-3311
amu_ethics@aichi-med-u.ac.jp
NO
愛知医科大学(愛知県)
2020 | Year | 07 | Month | 01 | Day |
Unpublished
Terminated
2020 | Year | 06 | Month | 01 | Day |
2020 | Year | 08 | Month | 05 | Day |
2020 | Year | 07 | Month | 01 | Day |
2022 | Year | 11 | Month | 30 | Day |
2020 | Year | 06 | Month | 03 | Day |
2022 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046387